Cargando…

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer

Detalles Bibliográficos
Autor principal:	Vrieling, Alina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323281/ https://www.ncbi.nlm.nih.gov/pubmed/30687600 http://dx.doi.org/10.21037/tau.2018.10.17

Ejemplares similares

No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
por: Evers, Jelle, et al.
Publicado: (2020)

Adherence to the WCRF/AICR Cancer Prevention Recommendations and Risk of Recurrence in Non-muscle Invasive Bladder Cancer
por: van Zutphen, Moniek, et al.
Publicado: (2022)

Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer
por: van Zutphen, Moniek, et al.
Publicado: (2023)

Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer
por: Oszczudlowski, Maciej, et al.
Publicado: (2018)

Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer
por: Kweon, Tae Dong, et al.
Publicado: (2018)

Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
por: Tan, Wei Shen, et al.
Publicado: (2018)

The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
por: Pan, Chin-Chen
Publicado: (2018)

Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis
por: Beeren, Ivy, et al.
Publicado: (2022)

EORTC risk tables – their usefulness in the assessment of recurrence and progression risk in non–muscle–invasive bladder cancer in Polish patients
por: Borkowska, Edyta M., et al.
Publicado: (2013)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Previous Bladder Cancer History in Patients with High-Risk, Non–muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History
por: Mitrakas, Lampros P., et al.
Publicado: (2015)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
por: Vedder, Moniek M., et al.
Publicado: (2014)

Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer
por: Carta, Angela, et al.
Publicado: (2018)

Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer
por: Dalla, Emiliano, et al.
Publicado: (2022)

The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer
por: Abushamma, Faris, et al.
Publicado: (2021)

Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence
por: Yu, Seong Hyeon, et al.
Publicado: (2023)

Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors
por: Lee, Kyoung-Hwa, et al.
Publicado: (2018)

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
por: Zieger, Karsten, et al.
Publicado: (2009)

Understanding risk and refining surveillance following tumor resection for low grade non-muscle invasive bladder cancer
por: Peyton, Charles C., et al.
Publicado: (2018)

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions
por: Zuniga, Kyle B., et al.
Publicado: (2020)

A single immediate instillation of chemotherapy for non-muscle invasive bladder cancer: in all patients?
por: Sylvester, Richard
Publicado: (2018)

Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2023)

Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
por: Le Goux, Constance, et al.
Publicado: (2020)

Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
por: Ripping, Theodora M., et al.
Publicado: (2021)

An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
por: Oosterlinck, Willem, et al.
Publicado: (2018)

Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
por: Hurle, Rodolfo, et al.
Publicado: (2020)

Non-muscle invasive bladder cancer risk stratification
por: Isharwal, Sumit, et al.
Publicado: (2015)

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
por: Ajib, Khaled, et al.
Publicado: (2018)

Editorial on the value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer
por: Oosterlinck, Willem, et al.
Publicado: (2018)

Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer
por: Batura, Deepak
Publicado: (2018)

The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2022)

Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy
por: Luchini, Claudio, et al.
Publicado: (2017)

Clinical benefit to regionalization of care for muscle invasive bladder cancer
por: Haque, Waqar, et al.
Publicado: (2018)

Predicting Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer in Korean Patients: A Comparison of the EORTC and CUETO Models
por: Choi, Se Young, et al.
Publicado: (2014)

Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus
por: Ahn, Ji Hoon, et al.
Publicado: (2016)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

Positive association of collagen type I with non-muscle invasive bladder cancer progression
por: Brooks, Michael, et al.
Publicado: (2016)

The association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytes
por: Krpina, Kristian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1pj31ngndqdfqebk0r7d3mcato